Real relief. Real science.
Pioneering Neuro-Therapeutics
CBX Therapeutics is dedicated to developing cutting-edge, evidence-based cannabinoid formulations. Our focus is on developing a product for immediate relief for tremors today, while simultaneously working towards advanced neuroprotection for a healthier future. We blend rigorous science with natural compounds to address pressing neurological needs.
Our Solution
CLARIFY - Discovery Platform
Combinatorial Discovery
Rigorous Funneling
Predictive Modeling
Translational Output
1st Lead Asset CLARIFY(ied)
Fast-acting oral disintegrating tablet for Parkinson's patients
Portfolio
TPP-1
Fast-acting ODT for Parkinsonian tremor (2 regulatory variants).
TPP-2
Neuroprotection solution addressing broader neurological wellness.
TPP-3
Novel target for disease modifying mechanism.
Our Edge: What Makes CBX Different
We plan and execute…
Dr. Shimon Lecht
Founder & CEO
  • Scientist–entrepreneur
  • Business strategy
  • Translational R&D
Eliyahu Shalom
Co-Founder & Director
  • Venture building
  • Business development
  • Operations & Finance
Dr. Tatiana Zvagelsky
Head of R&D
  • Research & Discovery
  • Analytics & Quality
  • Project management
Daniel Abrahami
US Commercial Lead
  • Go-to-market strategy
  • Channel partnerships
  • Growth operations
Trusted by our investors:
Real people are suffering.

Let’s keep doing the hard work that matters, together.
Real relief. Real science.
info@cbxtx.com
© 2025 CBX Therapeutics Ltd.